Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone

PACE - Pacing and Clinical Electrophysiology

Volumn 27, Issue 7, 2004, Pages 901-909

  Aiba, Takeshi ^a   Shimizu, Wataru ^a   Inagaki, Masashi ^a   Satomi, Kazuhiro ^a   Taguchi, Atsushi ^a   Kurita, Takashi ^a   Suyama, Kazuhiro ^a   Aihara, Naohiko ^a   Sunagawa, Kenji ^a   Kamakura, Shiro ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Amiodarone; Dispersion; Prognosis; QT interval; Ventricular tachycardia

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG TERM CARE; MALE; PREDICTION; PROGNOSIS; QT DISPERSION; QT PROLONGATION; RECURRENT DISEASE; TREATMENT OUTCOME;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 3242813752     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2004.00557.x     Document Type: Article

References (33)

1. Kuo CS, Munakata K, Reddy CP, et al. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983; 67:1356-1367.
2. Zabel M, Portnoy S, Franz M. Electrocardiographic indexes of dispersion of ventricular repolarization: An isolated heart validation study. J Am Coll Cardiol 1995; 25:746-752.
3. Zabel M, Lichtlen PR, Haverich A, et al. Comparison of ECG variables of dispersion of ventricular repolarization with direct myocardial repolarization measurements in the human heart. J Cardiovasc Electrophysiol 1998; 9:1279-1284.
4. Priori SG, Napolitano C, Diehl L, et al. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994; 89:1681-1689.
5. Perkiömäki JS, Koistinen MJ, Yli-Mäyry S, et al. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995; 26:174-179.
6. Grancy JM, Garratt CJ, Woods KL, et al. QT dispersion and mortality after myocardial infarction. Lancet 1995; 345:945-948.
7. Shimizu W, Kamakura S, Ohe T, et al. Diagnostic value of recovery tine measured by body surface mapping in patients with congenital long QT syndrome. Am J Cardiol 1994; 74:780-785.
8. Aiba T, Inagaki M, Shimizu W, et al. Recovery time dispersion measured from 87-lead body surface potential mapping as a predictor of sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol 2000; 11:968-974.
9. Shimizu W, Kamakura S, Kurita T, et al. Influence of epinephrine, propranolol, and atrial pacing on spatial distribution of recovery time measured by body surface mapping in congenital long QT syndrome. J Cardiovasc Electrophysiol 1997; 8:1102-1114.
10. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long QT syndrome. Circulation 1997; 96:2038-2047.
11. Shimizu W, Antzelevitch C. Cellular basis for the electrocardio-graphic features of LQT1 form of the long QT syndrome. Effects of β adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998; 98:2314-2322.
12. Shimizu W, Antzelevitch C. Cellular and ionic basis for T wave alternans under long QT conditions. Circulation 1999; 99:1499-1507.
13. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation 1998; 98:1928-1936.
14. Tanabe Y, Inagaki M, Kurita T, et al. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 2001; 37:911-919.
15. Shimizu W, Tanabe Y, Aiba T, et al. Differential effects of β blockade on dispersion of repolarization in absence and presence of sympathetic stimulation between LQT1 and LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 2002; 39:1984-1991.
16. + current. Circulation 2001; 103:1317-1324.
17. Amiodarone Trials Meta-analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomized trials. Lancet 1997; 350:1417-1424.
18. Hii JTY, Wyse DG, Gillis AM, et al. Precordial QT interval dispersion as a marker of torsade de pointes, disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992; 86:1376-1382.
19. van Opstal JM, Schoenmakers M, Verduyn SC, et al. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation 2001; 104:2722-2727.
20. Meierhenrich R, Helguera ME, Kidwell GA, et al. Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome. Int J Cardiol 1997; 60:289-294.
21. Grimm W, Steder U, Menz V, et al. Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events. Clinical Cardiol 1997; 20:107-110.
22. Cui G, Sen L, Sager P, et al. Effects of amiodarone, sematilide, and sotalol on QT dispersion. Am J Cardiol 1994; 74:896-900.
23. Sicouri S, Moro S, Litovsky S, et al. Chronic amiodarone reduced transmural dispersion of repolarization in the canine heart. J Cardiovasc Electrophysiol 1997; 8:1269-1279.
24. Drouin E, Lande G, Charpentier F. Amiodarone reduces transmural heterogeneity of repolarization in the human heart. J Am Coll Cardiol 1998; 32:1063-1067.
25. Merot J, Charpentier F, Poirier JM, et al. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: Interactions with acute sotalol. Cardiovasc Res 1999; 44:303-314.
26. Zabel M, Hohnloser S, Behrens S, et al. Differential effects of d-sotalol, quinidine, and amiodarone on dispersion of ventricular repolarization in the isolated rabbit heart. J Cardiovasc Electrophysiol 1997; 8:1239-1245.
27. Ks, in canine model of malignant ventricular arrhythmia. Circulation 1999; 100:1917-1923.
28. Brendorp B, Elming H, Jun L, et al. QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide. Circulation 2001; 103:1422-1427.
29. Vrtovec B, Delgado R, Zewail A, et al. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 2003; 107:1764-1769.
30. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36:1749-1766.
31. Zabel M, Klingenheben T, Franz MR, et al. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction, results of a prospective, long-term follow-up study. Circulation 1998; 97:2543-2543.
32. K and its response to quinidine in experimental healed myocardial infarction. J Cardiovasc Electrophysiol 1999; 10:844-854.
33. Maltsev VA, Sabbah HN, Undrovinas AI. Late sodium current is a novel target for amiodarone: Studies in failing human myocardium. J Mol Cell Cardiol 2001; 33:923-932.